Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

Abstract MDMA (3,4-methylenedioxymethamphetamine or “ecstasy”) is a recreationally used drug with remarkable and characteristic prosocial effects. In spite of abundant attention in the scientific literature, the mechanism of its prosocial effects has not been elucidated in humans. Recently, research in animals has suggested that the neuropeptide oxytocin may induce these effects. In a double blind, randomized, crossover, and placebo-controlled study in 15 healthy volunteers we assessed blood oxytocin and MDMA concentrations and subjective prosocial effects after oral administration of 100 mg MDMA or placebo. MDMA induced a robust increase of blood oxytocin concentrations and an increase of subjective prosocial feelings. Within subjects, the variations in these feelings were significantly and positively correlated with variation in oxytocin levels, and the correlations between these feelings and oxytocin were significantly stronger than those between these feelings and blood MDMA levels. MDMA induces oxytocin release in humans, which may be involved in the characteristic prosocial effects of ecstasy.

[1]  A. Campbell,et al.  Attachment, aggression and affiliation: The role of oxytocin in female social behavior , 2008, Biological Psychology.

[2]  J. Amico,et al.  A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans. , 1983, The Journal of clinical endocrinology and metabolism.

[3]  P. Whitaker-Azmitia,et al.  Further studies in the developmental hyperserotonemia model (DHS) of autism: Social, behavioral and peptide changes , 2008, Brain Research.

[4]  L. Young,et al.  Oxytocin, vasopressin and pair bonding: implications for autism , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[5]  Peter Kirsch,et al.  Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans , 2005, The Journal of Neuroscience.

[6]  Larry J. Young,et al.  The neurobiology of social recognition, approach, and avoidance , 2002, Biological Psychiatry.

[7]  A. Winstock,et al.  Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. , 2001, Drug and alcohol dependence.

[8]  A. Bond,et al.  Physiological and psychological measures in anxious patients , 1974, Psychological Medicine.

[9]  J P Kassirer,et al.  What is a differential diagnosis? , 1990, Hospital practice.

[10]  U. Fischbacher,et al.  Oxytocin Shapes the Neural Circuitry of Trust and Trust Adaptation in Humans , 2008, Neuron.

[11]  Gareth Leng,et al.  Dendritic peptide release and peptide-dependent behaviours , 2006, Nature Reviews Neuroscience.

[12]  I. McGregor,et al.  Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. , 2003, European journal of pharmacology.

[13]  G. Gimpl,et al.  The oxytocin receptor system: structure, function, and regulation. , 2001, Physiological reviews.

[14]  B. Sessa.  Is there a case for MDMA-assisted psychotherapy in the UK? , 2006, Journal of Psychopharmacology.

[15]  A. Kiss,et al.  Some assessments of the amygdala role in suprahypothalamic neuroendocrine regulation: a minireview. , 2007, Endocrine regulations.

[16]  D. Nutt,et al.  MDMA, politics and medical research: Have we thrown the baby out with the bathwater? , 2007, Journal of psychopharmacology.

[17]  L. Simpson.  Animal Studies , 2004, Psychopharmacologia.

[18]  A. Sanfey.  Social Decision-Making : Insights from Game Theory and Neuroscience , 2022 .

[19]  R. Verkes,et al.  A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers , 2006, Journal of psychopharmacology.

[20]  Philip B. Mitchell,et al.  Oxytocin Increases Gaze to the Eye Region of Human Faces , 2008, Biological Psychiatry.

[21]  D. Amaral,et al.  The amygdala: is it an essential component of the neural network for social cognition? , 2003, Neuropsychologia.

[22]  P. Veinante,et al.  Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala , 2005, Science.

[23]  Larry J. Young,et al.  Neuropeptidergic regulation of affiliative behavior and social bonding in animals , 2006, Hormones and Behavior.

[24]  J. Rosen,et al.  Animal studies of amygdala function in fear and uncertainty: Relevance to human research , 2006, Biological Psychology.

[25]  D. E. Nichols,et al.  Structure‐Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs? a , 1990, Annals of the New York Academy of Sciences.

[26]  J. Buitelaar,et al.  Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers , 2008, Psychopharmacology.

[27]  M. Geyer,et al.  Acute Psychological and Neurophysiological Effects of MDMA in Humans , 2002, Journal of psychoactive drugs.

[28]  T. Lundeberg,et al.  The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms. , 1993, Acta physiologica Scandinavica.

[29]  T. Waldron.  "Further studies ...' , 1991, The Lancet.

[30]  A. Parrott.  The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review , 2007, Psychopharmacology.

[31]  P. Zak,et al.  Oxytocin Increases Generosity in Humans , 2007, PloS one.

[32]  I. McGregor,et al.  High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)-induced Fos expression in a region-specific manner , 2007, Neuroscience.

[33]  H. Pincus,et al.  DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders. , 1994, Hospital & community psychiatry.

[34]  K. Aitchison,et al.  Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population , 2006, Journal of psychopharmacology.

[35]  R. Landgraf,et al.  Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication , 2004, Frontiers in Neuroendocrinology.

[36]  M. Manning,et al.  Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges. , 2007, Biochemical Society transactions.

[37]  Michael Davis,et al.  The amygdala , 2000, Current Biology.

[38]  R. Adolphs.  Cognitive neuroscience: Cognitive neuroscience of human social behaviour , 2003, Nature Reviews Neuroscience.

[39]  C. R. Cloninger,et al.  Differential diagnosis of personality disorders by the seven-factor model of temperament and character. , 1993, Archives of general psychiatry.

[40]  S. Herpertz,et al.  Oxytocin Improves “Mind-Reading” in Humans , 2007, Biological Psychiatry.

[41]  I. McGregor,et al.  A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”) , 2007, Neuroscience.

[42]  R. Ebstein,et al.  Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition , 2008, Molecular Psychiatry.

[43]  W. Armstrong.  The neurophysiology of neurosecretory cells , 2007, The Journal of physiology.